VS4-26328-21400
2 vaccinations
3 coded responses
15 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 606 / IL
- Registered
- 2021-01-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-07
Registered in v-safe
-
2021-01-07
Dose 1 — Pfizer-BioNTech
-
2021-01-07
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-07
Report sent to call center — day 0, dose 1Be unable to do your normal daily activitiesno matching call case
-
2021-01-08
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-13
- 2021-01-16
- 2021-01-21
-
2021-01-28
Dose 2 — Pfizer-BioNTech
- 2021-02-04
- 2021-02-11
- 2021-02-18
- 2021-02-27
-
2021-03-04
Survey response — day 35, dose 2MedDRA: Maternal exposure during pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-11
Survey response — day 42, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-29
Survey response — 3 months, dose 2MedDRA: Exposure during pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: PregnancyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-29
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-07 | Pfizer-BioNTech | |
| 2 | 2021-01-28 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-29 | Unsuccessful |
1 report(s) with no call case — see the timeline.
Free text
Release 5 — day 35, dose 2
Symptoms: Pregnancy
Release 5 — day 42, dose 2
Symptoms: Pregnancy
Release 8 — 3 months, dose 2
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Exposure during pregnancy | ✓ | ✓ | ✓ |
| SD | Maternal exposure during pregnancy | ✓ | ✓ | ✓ |
| SD | Pregnancy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release